[1]
2010. Cost/effectiveness model of dabigatran in the prevention of venous thromboembolism in major orthopedic surgery: Adaptation for Italy. Farmeconomia. Health economics and therapeutic pathways. 11, 2 (Jun. 2010), 91–101. DOI:https://doi.org/10.7175/fe.v11i2.183.